STOCK TITAN

Braskem board approves safety committee rules

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

Braskem S.A.'s Board approved internal rules for its Safety, Environment and Health Committee on October 22, 2026. The committee is a permanent advisory body to the Board.

The committee has three to six members serving two-year terms; the Board appoints them from among its directors or external members with relevant technical expertise and experience. Its remit includes reviewing safety, environmental and health policies, significant incidents and related management responses, and relevant risks and mitigation plans. Members must disclose conflicts and may not deliberate or otherwise intervene on the affected matter. The rules require an annual assessment of the committee's performance and effectiveness.

Committee membership 3 to 6 members The Board appoints members from among directors and external members with relevant expertise.
Member term 2 years The term coincides with the term of the Board of Directors.
Ordinary meeting frequency Monthly Meetings follow the approved Annual Calendar.
Meeting materials advance period At least 7 calendar days A majority may set a shorter deadline, but not less than 48 hours.
Shortest permitted meeting-material deadline 48 hours The minimum when a majority sets a shorter deadline.
Meeting quorum More than half of members Minimum quorum required to hold a meeting.
Draft minutes circulation Within 7 business days After the meeting, for members' consideration.
Committee performance assessment Annually Assessment covers performance and effectiveness of meetings, processes and governance practices.
Corporate Risk Matrix technical
"risks included in the Corporate Risk Matrix"
Basic Agenda technical
"the Basic Agenda for the ordinary meetings"
Brazilian Corporation Law regulatory
"the provisions of the Brazilian Corporation Law"
Shareholders' Agreement regulatory
"Shareholders' Agreement filed at the Company's headquarters"
conflict of interest regulatory
"in a situation of conflict of interest"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What quorum is required for BAK's committee meetings?

The minimum quorum is more than half of the committee's members. Members may attend in person or remotely by telephone, videoconference or another means that allows simultaneous communication.

When must draft minutes of BAK committee meetings be sent to members?

Draft minutes must be sent to members within seven business days after the meeting for their consideration. The committee's recommendations are recorded in minutes and made available on Braskem's Governance Portal after member validation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934


For the month of November, 2026

(Commission File No. 1-14862 )

 


 

BRASKEM S.A.

(Exact Name as Specified in its Charter)

 

N/A

(Translation of registrant's name into English)

 


 

Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil

(Address of principal executive offices)

 


 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.

 

 
 

INTERNAL RULES OF THE SAFETY, ENVIRONMENT AND HEALTH COMMITTEE OF BRASKEM S.A. INTERNAL RULES OF THE SAFETY, ENVIRONMENT AND HEALTH COMMITTEE OF BRASKEM S.A. 1. Objectives The Safety, Environment and Health Committee (“CSMS” or “Committee”) of Braskem S.A. (“Braskem” or “Company”) is the statutory and permanent advisory body to Braskem's Board of Directors ("CA" or "Board") in relation to the matters described in item 2 of these Internal Rules ("Rules"). In the exercise of their duties, the Committee members shall act in strict compliance with the Company's mission and values and conduct their activities in accordance with corporate governance best practices, the provisions of Law No. 6,404, dated December 15, 1976 (the "Brazilian Corporation Law"), as amended, the regulations issued by the Brazilian Securities and Exchange Commission (“CVM”), the Shareholders' Agreement filed at the Company's headquarters, where applicable, the Company's Bylaws ("Bylaws"), and this Rules. CSMS members shall comply with and ensure compliance with this Rules, exercising their duties with loyalty and due care and maintaining the confidentiality of any information to which they have access. 2. Attributions The CSMS shall: i. ii. iii. iv. v. vi. support the Board of Directors on monitoring the implementation of the guidelines established in the Safety, Environment and Health Policies; evaluate, prior to the resolution by the Board of Directors, the proposals from Braskem's Executive Management regarding updates to Safety, Environment and Health Policies; review Company information concerning significant Safety, Environment and Health incidents with a high accident potential and/or significant reputational risk, with special focus on lessons learned and management's response; propose to the Board the disclosure, in the Company's annual reports, of the activities performed by the Committee whenever deemed appropriate; express its opinion on Safety, Environment and Health-related matters whenever necessary for the Board's review and consideration; propose amendments to these Rules to the Board of Directors whenever deemed necessary, in accordance with Braskem's Bylaws, other documents approved by the Board, and applicable legislation; vii. viii. ix. x. xi. approve, annually, the calendar of ordinary meetings for the following year; annually approve the Basic Agenda for the ordinary meetings of the following year, upon proposal by its Chairperson, covering matters within the Committee's scope and other activities required to address assignments established by the Board; propose that management engage external consultants who may, in specific situations, contribute to the Committee's activities, observing Braskem's established procurement procedures; evaluate the risks included in the Corporate Risk Matrix and the respective mitigation plans related to matters within its scope of responsibility; and conduct an annual formal assessment of its performance and the effectiveness of its meetings, processes, and governance practices, reporting the results, recommendations, and improvement plans to the Board of Directors. 3. Operation of the CSMS 3.1. Composition and Term of Office The CSMS is composed of at least three (3) and up to six (6) members appointed by the Board of Directors from among the effective and alternate members of the Board of Directors and/or external members with relevant technical expertise and experience, observing the provisions of the Shareholders' Agreements filed at the Company's headquarters. The Coordinator of the CSMS shall be appointed by the Board of Directors, subject to the provisions of the Shareholders' Agreement filed at the Company's headquarters. The term of office of the CSMS members shall be two (2) years and shall coincide with the term of office of the Board of Directors. The term of office of members of the Board of Directors, whether effective or alternate, shall commence on the date of their appointment by the Board of Directors, while the term of office of external members shall commence upon execution of the respective instrument of investiture as Committee member. The term of office of any member shall terminate upon: (i) expiration of the term of office; (ii) resignation; or (iii) removal, at any time, by the Board of Directors. If a member of the CSMS permanently ceases holding office as a member of the Board of Directors before the end of the respective term of office, the Board of Directors shall appoint a replacement. The position of member of the CSMS is personal and non-delegable. 3.2. Coordination The CSMS Coordinator will have the following duties: i. ii. iii. iv. v. vi. vii. viii. ix. x. propose changes to the CSMS, when necessary, in the Basic Agenda and in the approved Annual Calendar, considering the recommendations of the other members of the CSMS; ratify the agenda of the regular meetings of the CSMS, before its forwarding, by the Executive Secretary of the CA ("Secretary of Governance" or "S-CA"), to the members of this Committee; call, conduct and coordinate the meetings of the CSMS; determine the need for extraordinary meetings and propose the dates on which such meetings will be held and their respective agendas, without prejudice to the right of the other members to request that such meetings be called; ensure that the call, agenda and support material for the meetings are forwarded to the members of the CSMS, by the S-CA, within the period stipulated in these Rules; invite, whenever necessary or appropriate, members of the Board, Braskem officers, other employees, external consultants and any other person holding information relevant to the purpose of the meeting. Such invitations shall be made with the support of the S-CA; forward to the CA the analyses, opinions and reports prepared within the scope of the CSMS and that must be submitted to the CA; forward to Management any proposal approved by the Committee regarding the engagement of external consultants to support the Committee's activities, in accordance with the Company's procurement procedures; ensure that the draft minutes of the meetings are forwarded to the members of the Committee, for consideration, within seven (7) business days after the meeting; and to present to the Board of Directors any proposals for updating these Rules. 3.3. Meetings The CSMS develops its activities primarily through working meetings and, for this purpose, meets ordinarily monthly, according to the approved Annual Calendar and, extraordinarily, whenever the CSMS Coordinator or any of its members deems it necessary, in alignment with the CSMS Coordinator, or when required by the circumstances. The ordinary meetings of the CSMS to consider matters of deliberation of the Board of Directors shall preferably be held at least seven (7) days in advance of the dates scheduled for the Meetings of Braskem's Board of Directors ("RCA" or "RCAs"), which may be in a shorter period of time, but always prior to the holding of the RCAs. The calls, agendas, as well as the support materials for the meetings must be made available to the members of the Committee, by the S-CA, at least seven (7) calendar days in advance of the date of the meeting, unless the majority of its members set a shorter deadline, but not less than forty-eight (48) hours, in which case a duly instructed agenda must be made available. The meetings of the CSMS shall be held, preferably, at Braskem's main office, and may be held remotely, by means of telephone conference, videoconference or by any other means of communication that allows the identification of the member of the Committee and simultaneous communication with all other persons present at the meeting, and recording is not allowed. In case of remote meetings, it will be the individual and exclusive responsibility of each member of the CSMS to adopt all necessary measures to ensure the strict confidentiality of the meetings, and access by people not authorized by the CSMS Coordinator to any information handled in the meeting is strictly prohibited. The means of communication to be used by the member of the Committee must be the one indicated by the Company's Information Security Department. If it is impossible to use the indicated means, it will be up to the member of the Committee to inform S CA in advance of the means of communication that will be used, so that the Information Security Department can carry out the validation. Preferably, all members of the CSMS should be present at all meetings, whether in person or by means of telephone conference, videoconference or any other means of communication. The minimum quorum required to hold a meeting must be more than half of the members. The member of the CSMS who is unable to attend the meeting must inform the CSMS Coordinator in advance and indicate, if applicable, which member will represent him, provided that such occasional representation shall not constitute a delegation, as set forth in item 3.1 of these Rules. Whenever the Coordinator of the CSMS is unable to attend a meeting, he or she shall notify the other members in advance and designate a substitute. The recommendations of the CSMS shall be recorded in minutes prepared by the S-CA and, after validation by the members of the CSMS, shall be made available on Braskem's Governance Portal. The minutes shall be archived by the Corporate Governance Department at the Company's offices. 3.4. Conflict of Interest If any of the members of the Committee is in a situation of conflict of interest with a certain matter to be considered, they must promptly disclose the conflict to the Coordinator or to the S-CA, being prevented from deliberating or otherwise intervening in the subject matter of the conflict. The impediment of the participation of the member will be recorded in the minutes of the meeting. If the member fails to disclose such conflict of interest, any other Committee member who becomes aware of it shall do so. Exceptionally, to protect its interests, the Company, by decision of the Legal Department, may restrict members subject to a conflict of interest from accessing information and materials relating to the matter giving rise to the conflict, as well as to the part of the meeting that deals with the subject. 3.5. General Provisions The S-CA shall be responsible for supporting the CSMS in accordance with the duties set forth in the Internal Rules of the Board of Directors. All communications between the members of the CSMS and external advisors, whenever applicable, shall be conducted under a confidentiality regime. In the event of any conflict between these Rules and the Company's Bylaws, the latter shall prevail and these Rules shall be amended, to the extent necessary. These Internal Regulations were approved at the ordinary meeting of Braskem's Board of Directors held on October 22, 2026, and will be made available on the Company's website.

 

 
 

 
 

 
 

 
 

 
 

 

 
 

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 18, 2026

  BRASKEM S.A.
       
       
  By:      /s/     Carlos Augusto Machado Pereira de Almeida Brandão
     
    Name: Carlos Augusto Machado Pereira de Almeida Brandão
    Title: Chief Financial Officer

 

DISCLAIMER ON FORWARD-LOOKING STATEMENTS

 

This Notice to the Market may contain forward-looking statements. These statements are not historical facts, but rather are based on the current view and estimates of the Company's management regarding future economic and other circumstances, industry conditions, financial performance and results, including any potential or projected impact regarding the geological event in Alagoas and related legal procedures on the Company's business, financial condition and operating results. The words “project,” “believe,” “estimate,” “expect,” “plan”, “objective” and other similar expressions, when referring to the Company, are used to identify forward-looking statements. Statements related to the possible outcome of legal and administrative proceedings, implementation of operational and financing strategies and investment plans, guidance on future operations, the objective of expanding its efforts to achieve the sustainable macro objectives disclosed by the Company, as well as factors or trends that affect the financial condition, liquidity or operating results of the Company are examples of forward-looking statements. Such statements reflect the current views of the Company's management and are subject to various risks and uncertainties, many of which are beyond the Company’s control. There is no guarantee that the events, trends or expected results will actually occur. The statements are based on various assumptions and factors, including, but not limited to, general economic and market conditions, industry conditions and operating factors, availability, development and financial access to new technologies. Any change in these assumptions or factors, including the projected impact from the joint venture and its development of technologies, from the geological event in Alagoas and related legal procedures and the unprecedented impact on businesses, employees, service providers, shareholders, investors and other stakeholders of the Company could cause effective results to differ significantly from current expectations. For a comprehensive description of the risks and other factors that could impact any forward-looking statements in this document, especially the factors discussed in the sections, see the reports filed with the Brazilian Securities and Exchange Commission (CVM). This Notice to the Market does not constitute any offer of securities for sale in Brazil. No securities may be offered or sold in Brazil without being registered or exempted from registration, and any public offer of securities carried out in Brazil must be made through a prospectus, which would be made available by Braskem and contain detailed information on Braskem and its management, as well as its financial statements.


 

 

 

Keep reading